Pete Stavropoulos's Stock Ratings

Cantor Fitzgerald Analyst

Pete Stavropoulos is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

0.43%

Smart Score

46.1%

Overall Average Return Percentile

40th

Number of Ratings

49
Buy NowGet Alert
03/12/2025VYGRBuy Now
Voyager Therapeutics
$3.88
Pete Stavropoulos46%
ReiteratesOverweight → OverweightGet Alert
03/07/2025ARCTBuy Now
Arcturus Therapeutics
$13.73
Pete Stavropoulos46%
ReiteratesOverweight → OverweightGet Alert
03/04/2025PLRXBuy Now
Pliant Therapeutics
$1.72
Pete Stavropoulos46%
Reinstates → NeutralGet Alert
01/10/2025VYGRBuy Now
Voyager Therapeutics
$3.8847.49%
Pete Stavropoulos46%
→ $5.73Initiates → OverweightGet Alert
12/16/2024ARCTBuy Now
Arcturus Therapeutics
$13.73
Pete Stavropoulos46%
ReiteratesOverweight → OverweightGet Alert
12/09/2024KALVBuy Now
KalVista Pharma
$12.47
Pete Stavropoulos46%
ReiteratesOverweight → OverweightGet Alert
11/26/2024ALECBuy Now
Alector
$1.32
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
11/15/2024ANNXBuy Now
Annexon
$2.62
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
10/18/2024VSTMBuy Now
Verastem
$6.50
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
10/03/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
10/01/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/23/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/16/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/09/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/06/2024VERABuy Now
Vera Therapeutics
$27.41290.37%
Pete Stavropoulos46%
$107 → $107ReiteratesOverweight → OverweightGet Alert
08/08/2024PLRXBuy Now
Pliant Therapeutics
$1.72
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
08/06/2024ARCTBuy Now
Arcturus Therapeutics
$13.73
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
07/29/2024ALECBuy Now
Alector
$1.32
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
06/27/2024DNTHBuy Now
Dianthus Therapeutics
$20.74
Pete Stavropoulos46%
Initiates → OverweightGet Alert
06/20/2024ALECBuy Now
Alector
$1.32
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
06/18/2024JSPRBuy Now
Jasper Therapeutics
$5.22
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
06/05/2024ANNXBuy Now
Annexon
$2.62
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
05/09/2024ALECBuy Now
Alector
$1.32
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
04/24/2024ANNXBuy Now
Annexon
$2.62
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
04/03/2024ANNXBuy Now
Annexon
$2.62
Pete Stavropoulos46%
Reiterates → OverweightGet Alert
01/08/2024VERABuy Now
Vera Therapeutics
$27.41
Pete Stavropoulos46%
Initiates → OverweightGet Alert
10/12/2023JSPRBuy Now
Jasper Therapeutics
$5.2214.94%
Pete Stavropoulos46%
→ $60ReiteratesOverweight → OverweightGet Alert
09/22/2023ALECBuy Now
Alector
$1.32884.85%
Pete Stavropoulos46%
→ $13Initiates → OverweightGet Alert
09/19/2023RZLTBuy Now
Rezolute
$3.3748.37%
Pete Stavropoulos46%
→ $5ReiteratesOverweight → OverweightGet Alert
08/22/2023PLRXBuy Now
Pliant Therapeutics
$1.723562.79%
Pete Stavropoulos46%
→ $63ReiteratesOverweight → OverweightGet Alert
08/22/2023ARCTBuy Now
Arcturus Therapeutics
$13.73293.3%
Pete Stavropoulos46%
→ $54ReiteratesOverweight → OverweightGet Alert
08/22/2023ANNXBuy Now
Annexon
$2.62396.18%
Pete Stavropoulos46%
→ $13ReiteratesOverweight → OverweightGet Alert
08/08/2023ANNXBuy Now
Annexon
$2.62396.18%
Pete Stavropoulos46%
$18 → $13MaintainsOverweightGet Alert
08/01/2023ANNXBuy Now
Annexon
$2.62587.02%
Pete Stavropoulos46%
→ $18ReiteratesOverweight → OverweightGet Alert
07/17/2023ABOSBuy Now
Acumen Pharmaceuticals
$1.21974.38%
Pete Stavropoulos46%
→ $13ReiteratesOverweight → OverweightGet Alert
07/14/2023ARCTBuy Now
Arcturus Therapeutics
$13.73293.3%
Pete Stavropoulos46%
→ $54ReiteratesOverweight → OverweightGet Alert
06/28/2023RZLTBuy Now
Rezolute
$3.3748.37%
Pete Stavropoulos46%
$7 → $5MaintainsOverweightGet Alert
06/27/2023ORTXBuy Now
Orchard Therapeutics
Pete Stavropoulos46%
→ $15ReiteratesOverweight → OverweightGet Alert
05/18/2023ABOSBuy Now
Acumen Pharmaceuticals
$1.21974.38%
Pete Stavropoulos46%
→ $13Initiates → OverweightGet Alert
05/01/2023PLRXBuy Now
Pliant Therapeutics
$1.723562.79%
Pete Stavropoulos46%
$52 → $63MaintainsOverweightGet Alert
03/28/2023ORTXBuy Now
Orchard Therapeutics
Pete Stavropoulos46%
$3 → $15MaintainsOverweightGet Alert
03/20/2023IMNMBuy Now
Immunome
$8.50-5.88%
Pete Stavropoulos46%
→ $8Reiterates → OverweightGet Alert
03/14/2023ANNXBuy Now
Annexon
$2.62587.02%
Pete Stavropoulos46%
$22 → $18MaintainsOverweightGet Alert
03/09/2023JSPRBuy Now
Jasper Therapeutics
$5.2214.94%
Pete Stavropoulos46%
→ $60Reiterates → OverweightGet Alert
02/07/2023JSPRBuy Now
Jasper Therapeutics
$5.2214.94%
Pete Stavropoulos46%
$100 → $60Reiterates → OverweightGet Alert
01/23/2023PLRXBuy Now
Pliant Therapeutics
$1.722923.26%
Pete Stavropoulos46%
$40 → $52MaintainsOverweightGet Alert
11/02/2022ARCTBuy Now
Arcturus Therapeutics
$13.73220.47%
Pete Stavropoulos46%
$39 → $44MaintainsOverweightGet Alert
08/16/2022ANNXBuy Now
Annexon
$2.62739.69%
Pete Stavropoulos46%
$27 → $22MaintainsOverweightGet Alert
06/15/2022RZLTBuy Now
Rezolute
$3.37167.06%
Pete Stavropoulos46%
→ $9Initiates → OverweightGet Alert